...
首页> 外文期刊>Journal of Korean medical science >Hepatocellular carcinoma in the elderly: clinical characteristics, treatment, survival analysis in Korean patients older than 70 years.
【24h】

Hepatocellular carcinoma in the elderly: clinical characteristics, treatment, survival analysis in Korean patients older than 70 years.

机译:老年人肝细胞癌:70岁以上韩国患者的临床特征,治疗,生存分析。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The prevalence of hepatocellular carcinoma (HCC) has increased in recent years. However, HCC remains poorly characterized in elderly patients, and comprehensive data are limited. This study aimed to investigate the clinical characteristics, prognostic features and survival outcome of elderly HCC patients. We retrospectively analyzed 992 HCC patients treated at Dongsan Hospital from January 2003 to December 2007. The patients were divided into two age groups: < 70 yr (n = 813) and ≥ 70 yr (n = 179). Elderly HCC patients, compared to younger patients, had significantly higher incidence of females (31.3% vs 18.9%, P = 0.001), hepatitis C-related disease (HCV antibody positivity 26.3% vs 9.2%, P = 0.001) and comorbid condition (53.6% vs 32.1%), but lower rates of hepatitis B-related disease (HBs antigen positivity 31.3% vs 69.4%, P = 0.001). There were no significant differences in underlying liver function, stage and survival outcomes. Factors significantly influencing the prognosis of HCC were Child-Pugh grade, number of HCC, level of alpha-fetoprotein, presence of metastasis. The survival outcome of older patients with HCC was not different from that of younger patients. There were no differences between groups in independent factors influencing the prognosis of HCC. Therefore, determining the optimal management strategy for elderly HCC patients is important to improve survival and long-term outcomes.
机译:近年来,肝细胞癌(HCC)的患病率有所增加。但是,老年患者的肝癌特征仍然很差,并且综合数据有限。本研究旨在探讨老年肝癌患者的临床特征,预后特征和生存结局。我们回顾性分析了2003年1月至2007年12月在东山医院接受治疗的992例HCC患者。患者分为两个年龄段:<70岁(n = 813)和≥70岁(n = 179)。与年轻患者相比,老年HCC患者的女性发病率(31.3%vs 18.9%,P = 0.001),丙型肝炎相关疾病(HCV抗体阳性率为26.3%vs 9.2%,P = 0.001)和合并症明显更高( 53.6%对32.1%),但乙型肝炎相关疾病的发生率较低(HBs抗原阳性率为31.3%对69.4%,P = 0.001)。潜在的肝功能,分期和生存结果无显着差异。显着影响HCC预后的因素包括Child-Pugh分级,HCC数目,甲胎蛋白水平,是否存在转移。老年肝癌患者的生存结局与年轻患者无差异。两组之间影响肝癌预后的独立因素没有差异。因此,确定老年肝癌患者的最佳治疗策略对提高生存率和长期预后很重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号